Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03466372 · ClinicalTrials.gov registry record · NA

Innovative Gait Biofeedback Strategies for Stroke Rehabilitation

A NA study of Stroke, Cardiovascular and Gait, Hemiplegic, sponsored by Emory University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03466372 is a NA study of Stroke, Cardiovascular and Gait, Hemiplegic that has completed, run by Emory University. The registered enrollment target is 20 participants, below the 61-participant average among 4 other Stroke, Cardiovascular trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03466372, a NA study of Stroke, Cardiovascular and Gait, Hemiplegic, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The long-term study goal is to develop a more engaging, motivating gait biofeedback methodologies specifically designed for post-stroke gait training. The current project aims to address fundamental questions regarding the optimal methodology to deliver AGRF biofeedback during gait, and the feasibility and preliminary efficacy of AGRF progression protocols for improved gait patterns and gait function. The study objectives are to (1) evaluate the immediate effects of biofeedback training methodology on gait biomechanics; and (2) evaluate the feasibility and short-term effects on gait performance of a real-time biofeedback protocol incorporating progression criteria (similar to those employed during clinical rehabilitative training).

Interventions

  • BEHAVIORAL biofeedback

Study Locations (1)

Georgia

  • Emory Univeristy - Atlanta

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-03-22
Est. Completion 2018-10-03
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT03466372

The ClinicalTrials.gov registry entry for NCT03466372 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 4 other Stroke, Cardiovascular trials with a reported enrollment target (67% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke, Cardiovascular appearing as the primary indexed condition, and to 1 intervention - of which biofeedback is the first listed.

NCT03466372 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT03466372 about?

NCT03466372 is a clinical study titled "Innovative Gait Biofeedback Strategies for Stroke Rehabilitation". The long-term study goal is to develop a more engaging, motivating gait biofeedback methodologies specifically designed for post-stroke gait training. The current project aims to address fundamental questions regarding the optimal methodology to deliver AGRF biofeedback during gait, and the feasibil...

What is the current status of trial NCT03466372?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-03-22. Estimated completion is 2018-10-03.

What conditions does trial NCT03466372 study?

This clinical trial studies the following conditions: Stroke, Cardiovascular, Gait, Hemiplegic.

What interventions are being tested in trial NCT03466372?

The interventions under investigation include: biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT03466372?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03466372 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke, Cardiovascular

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.